Ticker	Volume	Price	Price Delta
DJIA	15,303.10	+8.60	0.06%
S&P 500	1,649.60	-0.91	-0.06%
Nasdaq	3,459.14	-0.27	-0.01%

Ticker

Volume

Price

Price Delta

DJIA

15,303.10

+8.60

0.06%

S&P 500

1,649.60

-0.91

-0.06%

Nasdaq

3,459.14

-0.27

-0.01%

Ticker	Volume	Price	Price Delta
STOXX 50	2,764.29	-12.49	-0.45%
FTSE 100	6,654.34	-42.45	-0.63%
DAX	8,305.32	-46.66	-0.56%

Ticker

Volume

Price

Price Delta

STOXX 50

2,764.29

-12.49

-0.45%

FTSE 100

6,654.34

-42.45

-0.63%

DAX

8,305.32

-46.66

-0.56%

Ticker	Volume	Price	Price Delta
Nikkei	14,612.50	+128.47	0.89%
Hang Seng	22,618.70	-51.01	-0.23%
S&P/ASX 200	4,983.50	-78.95	-1.56%

Ticker

Volume

Price

Price Delta

Nikkei

14,612.50

+128.47

0.89%

Hang Seng

22,618.70

-51.01

-0.23%

S&P/ASX 200

4,983.50

-78.95

-1.56%

Exchange: Bursa Malays
Sector: Consumer, Non-cyclical
Industry: Pharmaceuticals
Sub-Industry: Medical-Drugs

CCM Duopharma Biotech Bhd

+ Add to Watchlist

CCMD:MK

2.500 MYR 0.010 0.40%

Share this quote:

Post this quote on one of these sites:

Copy permanent URL

As of 04:44:41 ET on 05/23/2013.

Snapshot for CCM Duopharma Biotech Bhd (CCMD)

Open:	2.510	Day's Range:	2.490 - 2.540	Volume:	72,800
Previous Close:	2.510	52wk Range:	2.100 - 2.580	1-Yr Rtn:	+12.33%

Stock Chart for CCMD

No chart data available.

CCMD:MK 2.500

2.510

Interactive CCMD Chart

…

Previous Close

Key Statistics for CCMD

Current P/E Ratio (ttm)	13.3404
Estimated P/E(-)	-
Relative P/E vs. FBMKLCI	0.8228
Earnings Per Share (ttm)	0.1874
Est. EPS	-
Est. PEG Ratio	-
Market Cap (M MYR)	347.05
Shares Outstanding (M)	138.82
30 Day Average Volume	70,500
Price/Book (mrq)	2.0354
Price/Sale (ttm)	2.5649
Dividend Indicated Gross Yield	5.60%
Cash Dividend (MYR)	0.1050
Last Dividend	06/14/2013
5 Year Dividend Growth	-20.58%
Next Earnings Announcement	05/27/2013

mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CCMD

Revenue
Net Income (M/MYR)

Profit Margin (%)

Company Profile & Key Executives for CCMD

CCM Duopharma Biotech Berhad is an investment holding company. Through its subsidiaries, the Company manufactures, distributes, imports and exports pharmaceutical products and medicines.

Ariff Bin Abdul Shatar "Leonard"Chief Executive Officer	Chek Wu KongChief Financial Officer
Zainudin Bin IbrahimCOO/Chief Strategy Officer	Billy UrudraChief Commercial Officer

More Company Profile & Key Executives for CCMD

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.